ASH: Single Dose of Gene Therapy Effective in Hemophilia B

Share this content:
ASH: Single Dose of Gene Therapy Effective in Hemophilia B
ASH: Single Dose of Gene Therapy Effective in Hemophilia B

THURSDAY, Dec. 8, 2016 (HealthDay News) -- A single dose of an experimental gene therapy may benefit patients with hemophilia B, according to trial results presented at the annual meeting of the American Society of Hematology, held from Dec. 3 to 6 in San Diego.

In the combined phase 1/phase 2 trial, researchers gave a single dose of the gene therapy to nine adult hemophilia B patients who ranged in age from 18 to 52.

The patients' levels of factor IX rose to a level of around 30. Patients who got the gene therapy were able to stop getting infusions of the clotting factor.

"At these new levels, hemophilia patients do not typically need to self-treat with factor [IX] to avoid bleeding events," lead investigator Lindsey George, M.D., hematologist at Children's Hospital of Philadelphia, said in a hospital new release. "This represents a potential dramatic improvement in their quality of life and a shift in the way we think about treating hemophilia."

Children's Hospital of Philadelphia has a financial interest in a gene therapy company that spun off from the hospital. The senior author of the study was formerly a researcher at the hospital and now is president and chief scientific officer of the company.

Press Release
More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves New Parkinson's Add-On Drug Xadago

FDA Approves New Parkinson's Add-On Drug Xadago

To help prevent 'off' episodes among users of levodopa/carbidopa

Infant Mortality Down in United States From 2005 to 2014

Infant Mortality Down in United States From 2005 ...

Largest decreases seen for infants of Asian or Pacific Islander and non-Hispanic black women

Intensive Strategy Addresses Hypoxemia After Cardiac Surgery

Intensive Strategy Addresses Hypoxemia After Cardiac Surgery

Intensive alveolar recruitment strategy linked to less severe pulmonary complications after cardiac sx

is free, fast, and customized just for you!

Already a member?

Sign In Now »